2m 2m 2m 2m 2m 2m 2m
TAKEDA PHARM SP ADR (TAK)
NYSE
$16.48-$0.010 (-0.06%)
Price as of Jul 13, 2026 6:06 PM EDT- $52.9BMarket Cap
- 14.04%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TAKEDA PHARM SP ADR (TAK)
$16.48-$0.010 (-0.06%)
TAK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.49 | ||
Change | -$0.07 (-0.42%) | ||
Open | $16.52 | ||
High | $16.61 | ||
Low | $16.45 | ||
Previous Close | $16.56 | ||
Volume | 2,565,845 | ||
30-Day Average Volume | 2,626,416 | ||
1-Week Change | -2.37% | ||
1-Month Change | 3.65% | ||
1-Year Change | 14.04% | ||
3-Year Change | 19.68% | ||
5-Year Change | 22.20% | ||
Fundamentals | |||
Shares Outstanding | 3.2B | ||
Total Assets | $15.5T | ||
Market Cap | $52.9B | ||
Enterprise Value | -$542.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 9.35% | ||
Trailing Annual Dividend Yield | 3.82% | ||
Ex-Dividend Date | 03/31/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield